The prostate-specific antigen test is a blood test that measures the levels of a protein called PSA, which is produced by the prostate gland. It is commonly used as a screening tool for prostate conditions, including prostate cancer. Elevated PSA levels can indicate various prostate issues, but it does not necessarily mean cancer. The test helps in early detection, monitoring treatment response, and determining the need for further evaluation
A PSA level above 4.0 ng/mL is often considered an indicator of potential prostate cancer. However, it's important to note that PSA levels alone cannot confirm cancer, and further testing is needed, such as a biopsy.
Prostate cancer is treatable and potentially curable, especially when detected early. Treatment options include surgery, radiation therapy, hormone therapy, and chemotherapy. The effectiveness of treatment depends on factors such as the stage of cancer and individual patient characteristics. Consult with a healthcare professional for personalized advice.
Men should discuss prostate screening with their healthcare provider. Generally, screenings start at age 50, but may begin earlier for higher-risk individuals. Frequency depends on individual factors and should be determined through a conversation with a healthcare professional.
A positive PSA test does not necessarily indicate prostate cancer. Further evaluation, such as a biopsy, is required to confirm the presence of prostate cancer.
The best time to get a PSA test is in the morning, as PSA levels tend to be slightly higher in the morning due to natural fluctuations. It is recommended to avoid ejaculation or vigorous exercise for 48 hours before the test, as these activities can temporarily elevate PSA levels.
